Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.

Implantable Cardioverter Defibrillator (ICD)

Implantable Cardioverter Defibrillator (ICD)

An important part of the work up for patients with hypertrophic cardiomyopathy is an assessment of the risk of dangerous heart rhythms. Fortunately, for those patients at risk, there is now the option of protection in the form of an implantable cardioverter defibrillator (ICD).

An ICD is the most effective means of managing the risk of sudden cardiac arrest. This device is recommended for patients with hypertrophic cardiomyopathy with:

  • Septal wall thickness greater than 3cm
  • Ventricular arrhythmia on monitor
  • History of syncope
  • Family history of sudden cardiac death
  • Abnormal blood pressure response with exercise

Learn more about implantable cardioverter defibrillators (ICD).

Condition Spotlight

Your Health: Euan Ashley, MD, Discusses Hypertrophic Cardiomyopathy Watch Video
Deadly Heart Condition Yields to Screening and Prompt Treatment
Deadly Heart Condition Yields to Screening and Prompt Treatment Read Story
Hypertrophic Cardiomyopathy
Hypertrophic Cardiomyopathy Play Video | 59:57

Clinical Trials

Clinical trials are research studies that evaluate a new medical approach, device, drug, or other treatment. As a Stanford Health Care patient, you may have access to the latest, advanced clinical trials.

Open trials refer to studies currently accepting participants. Closed trials are not currently enrolling, but may open in the future.

Open Trials Closed Trials

Hypertrophic Cardiomyopathy Center

See a Stanford specialist to learn about your treatment options. Visit our clinic to make an appointment.

Boswell Building
300 Pasteur Drive
Stanford, CA 94305
Phone: 650-736-7878
Visit Clinic